HER-2/neu over expression in gall bladder adenocarcinoma: A quest for potential therapeutic target

HER-2/neu over expression in gall bladder adenocarcinoma: A quest for potential therapeutic target

Background: Gall bladder carcinoma (GBC) is an aggressive malignancy with high mortality and aggressive course, with palliation as the only available option. Objectives: To evaluate frequency of HER-2/neu overexpression in GBC and to seek its correlation, if any with conventional clinicopathological...

Full description

Bibliographic Details
Main Authors:	Pragya Jain, Surbhi Goyal, Geeta Chauhan, Kaushik Majumdar, Shahajad Ali, Puja Sakhuja, Anil K Agarwal
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2020-01-01
Series:	Indian Journal of Pathology and Microbiology
Subjects:	fluorescent in situ hybridization gall bladder adenocarcinoma her-2/neu immunohistochemistry
Online Access:	http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2020;volume=63;issue=2;spage=214;epage=220;aulast=Jain

Similar Items

EGFR and HER2neu Expression in Gall Bladder Carcinoma and Its Association with Clinicopathological Parameters - An Institutional Experience from North India
by: Inara Abeer, et al.
Published: (2021-03-01)

Role of HER2neu expression in gastric cancer
by: J S Sukanya, et al.
Published: (2021-01-01)

Inter-observer agreement in reporting HER 2 Neu protein over expression by immunohistochemistry
by: Ibrahim Al Haddabi, et al.
Published: (2014-01-01)

Study of human epidermal growth factor receptor (HER2/neu) expression in primary colorectal carcinoma in a tertiary care hospital
by: Mousmi Agrawal, et al.
Published: (2021-01-01)

Clinicopathological Significance and Prognostic Role of Her2neu Protein Expression in Patients with Carcinoma Stomach: A Prospective Study from Northern India
by: Abhilash V. B., et al.
Published: (2023-04-01)

Clinical and prognostic profile of Her2neu positive (non-luminal) intrinsic breast cancer subtype: comparison with Her2neu positive luminal breast cancers
by: Atif Ali Hashmi, et al.
Published: (2018-08-01)

HER-2/Neu and Hormone Receptor Analysis in Breast Carcinomas and Their Association with Clinicopathologic Parameters
by: Reşit Doğan Köseoğlu, et al.
Published: (2019-01-01)

HER-2/neu overexpression in breast cancer
by: Rana S. Aziz, et al.
Published: (2010-10-01)

Expression of Her-2/neu in extrahepatic cholangiocarcinoma
by: Shamekh R, et al.
Published: (2017-02-01)

HER-2/neu gene analysis on endoscopic biopsy samples and gastric resection materials in gastric carcinomas
by: Ali Zisan Genc, et al.
Published: (2019-12-01)

Study of gastrointestinal neoplasms, histopathologic and immunohistochemical correlation using HER-2/NEU, CK-7 and CK-20
by: Pramod Kumar Reddy M, et al.
Published: (2023-07-01)

Her-2 neu (Cerb-B2) expression in fine needle aspiration samples of breast carcinoma: A pilot study comparing FISH, CISH and immunocytochemistry
by: Kusum Kapila, et al.
Published: (2011-01-01)

Molecular Targeting of Her-2/neu Protein Is Not Recommended as an Adjuvant Therapy in Oral Squamous Cell Carcinoma and Oral Lichen Planus
by: Maryam Kouhsoltani, et al.
Published: (2015-12-01)

Prevalence of Her2-neu status and its clinicopathological association in newly diagnosed gastric cancer patients
by: Joseph Kattan, et al.
Published: (2022-11-01)

Her2neu Expression of Gastric and Lower Esophageal Carcinoma and its Correlation with Clinicopathological Findings in Tertiary Care Hospital in Eastern India
by: Dipsikha Chakraborty, et al.
Published: (2022-01-01)

Immunohistochemical expression of HER2/neu in colorectal carcinoma in Erbil city, Kurdistan Region
by: Lilav Adel Kamal, et al.
Published: (2019-12-01)

Quantitative real-time PCR assay with immunohistochemical evaluation of HER2/neu oncogene in breast cancer patients and its correlation with clinicopathological findings
by: Nadia Gheni, et al.
Published: (2020-01-01)

HER2/neu Oncogene and Sensitivity to the DNA-Interactive Drug Doxorubicin
by: Anne Mullin, et al.
Published: (2020-12-01)

Estudo comparativo entre os métodos LSAB®+ e Herceptest® para a detecção de HER-2/neu em carcinoma de mama A comparative study between LSAB®+ and Herceptest® in the detection of HER-2/neu in breast carcinoma
by: Alexandre de Oliveira Sales, et al.
Published: (2004-08-01)

Combined Expression of HGFR with Her2/neu, EGFR, IGF1R, Mucin-1 and Integrin α2β1 Is Associated with Aggressive Epithelial Ovarian Cancer
by: Bastian Czogalla, et al.
Published: (2022-10-01)

Role of p53 and Her2/Neu as a prognostic biomarker in breast carcinoma
by: Anamika Gupta, et al.
Published: (2023-01-01)

cERBB-2/Her-2 Neu Overexpression and Prognostic Significance in Uterine Carcinosarcoma
by: Huseyin Salih SEMIZ, et al.
Published: (2023-01-01)

Applicability and interpretation of HER2/Neu & PD-L1 stains in gastrointestinal tract tumours
by: Prasenjit Das, et al.
Published: (2021-01-01)

HER-2/neu expression in lesions of uterine cervix: Is it reliable and consistent?
by: Gupta Nidhi, et al.
Published: (2009-10-01)

HER 2 Expression in Gastric and Gastro-esophageal Junction (GEJ) Adenocarcinomas
by: Indu Rajagopal, et al.
Published: (2015-03-01)

Silencing of the HER2/neu Gene by siRNA Inhibits Proliferation and Induces Apoptosis in HER2/neu-Overexpressing Breast Cancer Cells
by: Timo Faltus, et al.
Published: (2004-11-01)

Correlation of histological grade with Estrogen, Progesterone and HER2/neu reactivity in breast cancer
by: Girishma Shrestha, et al.
Published: (2019-09-01)

HER-2/NEU Ekspresyonun Saptanmasinda İmmunohistokimyasal ve Fish Yöntemi Arasında Diskordansin Belirlenmesi Önemli midir?
by: Berna Bozkurt DUMAN, et al.
Published: (2014-07-01)

HER2 and Helicobacter pylori Status in Resected Gastric Cancers: A Pathological Study of a Gastroenterological Issue
by: Saraswathy Sreeram, et al.
Published: (2017-10-01)

Evaluation of estrogen and progesterone receptors and Her-2 expression with grading in the fine-needle aspirates of patients with breast carcinoma
by: Pampa Ch Toi, et al.
Published: (2018-01-01)

Frequency of Her2/Neu Immuno Histochemical Expression in Bladder Urothelial Carcinoma: A Study At CMH Quetta
by: Javeria Faridi, et al.
Published: (2022-07-01)

The Study of HER-2/neu, ER/PR Expression Using Immunohistochemistry (IHC) in the Iraqi Breast Cancer
by: Suhad Faisal Hatem, et al.
Published: (2016-06-01)

Anti-HER2/neu Antibody Reduces Chemotherapy-Induced Ovarian Toxicity—From Bench to Bedside
by: Mattan Levi, et al.
Published: (2020-12-01)

NEW INDICATORS OF HSP27 FUNCTIONAL STATE IN BREAST CANCER CELLS WITH DIFFERENT VARIANTS OF HER2/NEU-STATUS
by: E. V. Kaigorodova, et al.
Published: (2016-02-01)

Factors Influencing Lymph Node Positivity in HER2/neu+ Breast Cancer Patients
by: Katherine Englander, et al.
Published: (2023-02-01)

Status of estrogene, progesterone receptors and HER-2/neu expression in invasive breast cancer
by: Naghshvar F, et al.
Published: (2007-01-01)

Breast Cancer in Kirkuk City, Hormone Receptors Status (Estrogen and Progesterone) and Her-2/Neu and Their Correlation with Other Pathologic Prognostic Variables
by: Mahmoud Mohammed Mahmoud
Published: (2019-11-01)

Breast Cancer in Kirkuk City, Hormone Receptors Status (Estrogen and Progesterone) and Her-2/Neu and Their Correlation with Other Pathologic Prognostic Variables
by: Mahmoud Mohammed Mahmoud
Published: (2019-11-01)

Correlation of HER-2/neu Status with Estrogen (ER) & Progesterone (PR) Receptor in Breast Malignancies
by: Asma Rasheed, et al.
Published: (2020-12-01)

Biglycan-mediated upregulation of MHC class I expression in HER-2/neu-transformed cells
by: Karthikeyan Subbarayan, et al.
Published: (2018-04-01)